|Articles|June 7, 2017
Chesapeake IRB Announces Acquisition of MaGil IRB
Advertisement
Chesapeake IRB-technology-enabled independent institutional review board (IRB) that serves the clinical research industry-has acquired MaGil IRB.
The acquisition provides Chesapeake with additional AAHRPP-accredited review capacity and more staff, broadening its precense for CROs, pharma companes, and biotech companies.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Rethinking Site Support in 2026, GSK’s New Severe Asthma Approval, and Priority Review Momentum in Multiple Myeloma
2
Unlocking Unstructured Health Data: Scaling eSource-Enabled Clinical Trials
3
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
4
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
5